Morningstar

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases—according to Nature study

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

Whole-genome sequencing may optimize PARP inhibitor use for cancer patients

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led ...
The Scientist

Optimizing Illumina Long-Read Whole Genome Sequencing of Salivary DNA Using Oragene™ Collection Devices

Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...
GEN

At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...
Digi Times

Genomics, Illumina team up to capture Asia-Pacific whole genome sequencing market

Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...